Brief: Simcere Pharmaceutical Says Option To License Agreement Of Sim0500 With Abbvie
Jan 13 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR
RIGHTS
OUTSIDE GREATER CHINA
* OPTION TO LICENSE AGREEMENT OF SIM0500 WITH ABBVIE FOR
RIGHTS
OUTSIDE GREATER CHINA
* UNDER DEAL CO TO RECEIVE UPFRONT PAYMENT FROM ABBVIE,
ELIGIBLE
TO RECEIVE OPTION FEES & MILESTONE PAYMENTS OF UP TO $1.055
BILLION
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660